When was Pandorum founded?

Pandorum was founded in 2011 and raised its 1st funding round 1 year after it was founded.

Where is Pandorum located?

Pandorum is headquartered in Bengaluru, India. It is registered at EGF 4 & 5, Bangalore Bioinnovation Centre, Helix Biotech Park, Electronic City Phas, e 1, Bangalore, Bengaluru, Karnataka, India, 560100.

Which legal entities is Pandorum associated with?

Pandorum is associated with PANDORUM TECHNOLOGIES PRIVATE LIMITED.

How many employees does Pandorum have?

As of Aug 31, 2025, the latest employee count at Pandorum is 28.

Is Pandorum a funded company?

Pandorum is a funded company, having raised a total of $53M across 13 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on 2012.

How much is Pandorum worth?

The latest valuation of Pandorum is $***** as of Feb 09, 2026.

When was the latest funding round of Pandorum?

Pandorum's latest funding was a $***** Series B round on Mar 20, 2026, with participation from 1 investor.

What is the annual revenue of Pandorum?

Annual revenue of Pandorum is ₹3.53Cr as on Mar 31, 2025.

Where does Pandorum rank among its competitors?

Pandorum ranks 7th amongst 155 active competitors, of which 51 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was iHeart, which secured $5.44M in Sep, 2025.

Who are the top competitors of Pandorum?

Pandorum's top competitors include Orthofix, Ncardia and Ensoma. Among them, Pandorum secured the most recent funding round in March, 2026.

Pandorum - 2026 Company Profile, Team, Funding, Competitors & Financials

Pandorum is a series B company based in Bengaluru (India), founded in 2011 by Tuhin Bhowmick and Arun Chandru. It operates as a Developer of regenerative medicine and 3D tissues. Pandorum has raised $53M in funding from investors like Indian Angel Network, BTB Venture and We Founder Circle, with a current valuation of $*****. The company has 155 active competitors, including 51 funded and 16 that have exited. Its top competitors include companies like Orthofix, Ncardia and Ensoma.

Company Details

Developer of regenerative medicine and 3D tissues. It has developed a working 3D tissue through 3D printing and fabrication techniques. The products include bioengineered cornea which is a hydrogel formulation used for blindness, 3D hepatocyte spheroids for drug discovery and liver therapies, and exosome cell-free therapy for lung regeneration.

Website: pandorum.com
Social
Email ID: *****@pandorumtechnologies.in
Phone Number: +91 **********
Registered Address: EGF 4 & 5, Bangalore Bioinnovation Centre, Helix Biotech Park, Electronic City Phas, e 1, Bangalore, Bengaluru, Karnataka, India, 560100

Key Metrics

Founded Year

2011

Location

Bengaluru, India

Stage

Series B

Total Funding

$53M in 13 rounds

Latest Funding Round

Series B, Mar 20, 2026, $*****

Post Money Valuation

$***** as on Feb 09, 2026

Investors

Indian Angel Network & 79 more

Ranked

7^th among 155 active competitors

Annual Revenue

₹3.53Cr as on Mar 31, 2025

Employee Count

28 as on Aug 31, 2025

Similar Companies

Orthofix & 145 more

View Pandorum's full profile

Pandorum is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
PANDORUM TECHNOLOGIES PRIVATE LIMITED CIN: U72200KA2011PTC058650 , India, Active	May 16, 2011	$417K (As on Mar 31, 2025)	28 (As on Aug 01, 2025)

Pandorum has raised a total funding of $53M over 13 rounds. Its first funding round was on 2012. Its latest funding round was a Series B round on Mar 20, 2026 for $*****. 1 investor participated in its latest round. Pandorum has 25 institutional investors and 55 angel investors.

Here is the list of recent funding rounds of Pandorum:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 20, 2026	7005166	Series B	5445069	1910072	5427585	6588561
Oct 24, 2025	5272520	Series B	8084189	1902288	3945213	Ashish Kacholia & 10 more
Jan 25, 2024	4631638	Series A	6929240	1639174	5585772	We Founder Circle

Access funding benchmarks and valuations. Sign up today!

View details of Pandorum's funding rounds and investors

The founders of Pandorum are Tuhin Bhowmick and Arun Chandru. Tuhin Bhowmick is the CEO of Pandorum.

Here are the details of Pandorum's key team members:

Tuhin Bhowmick: Co-Founder & CEO & Director of Pandorum and founder of 1 other company. They serve on the board of 1 company.
Contact Info: 1 email address and 1 phone number
Arun Chandru: Co-Founder& CTO & Director of Pandorum and founder of 2 other companies, Pandorum Technologies and Pandorum Technologies. They serve on the board of 1 company.
Contact Info: 1 email address and 1 phone number

Pandorum's Board of Directors

Pandorum's board has 5 active members. Tuhin Bhowmick and Arun Chandru are part of team and Sailesh Tulshan, Sudipta Gautam and Sonal Asthana are independent board members.

Here is the list of Pandorum's board of directors:

Name	Type	Representing	Status	Duration
Tuhin Bhowmick	Team	-	Current	14y 8m
Arun Chandru	Team	-	Current	14y 8m
Sailesh Tulshan	Independent board member	-	Current	7y 5m
xtekhel	Independent board member	-	Current	9y 7m
amyscdp	Independent board member	-	Past	2y 8m
jmurlg{	Independent board member	-	Past	3y 1m

View details of Pandorum's Founder profiles and Board Members

Pandorum's employee count trend

Pandorum has 28 employees as of Aug 25. The total employee count is 8.0% more than what it was in Aug 24. Here is Pandorum's employee count trend over the years:

Uncover Pandorum's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Pandorum include Orthofix, Ncardia and Ensoma. Here is the list of Top 10 competitors of Pandorum, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Orthofix 1980, Lewisville (United States), Public	Developer of reconstructive and regenerative solutions for bone-related conditions	-	-	63/100
2nd	Ncardia 2011, The Hague (Netherlands), Series C	Company offering hiPSC based products and services for drug discovery and development	$77.4M	Epimede, Vesalius Biocapital Partners & 9 others	62/100
3rd	Ensoma 2019, Boston (United States), Series B	Provider of in vivo stem cell modification technologies and vector-based drug delivery tool	$205M	5AM Ventures, Arix Bioscience & 18 others	62/100
4th	InSphero 2009, Schlieren (Switzerland), Series D	Developer of cell based assays for drug screening	$35M	Redalpine, ZEISS & 8 others	62/100
5th	Avita Medical 1992, Cambridge (United Kingdom), Public	Regenerative and Respiratory Medicine product company	-	Orbimed, NorthStar Impact & 6 others	62/100
6th	Organogenesis 1985, Canton (United States), Public	Regenerative tissue innovations for advanced wound care and surgical solutions	$30M	Spring St. Group, Eastward Capital Partners ... & 2 others	60/100
7th	Pandorum 2011, Bengaluru (India), Series B	Developer of regenerative medicine and 3D tissues	$53M	Kotak Investment Advisors, Indian Angel Network ... & 78 others	65/100
8th	TreeFrog Therapeutics 2018, Talence (France), Series B	Developer of stem cells and organoids using proprietary technology	$84.2M	XAnge, Leonard Green and Partners & 10 others	59/100
9th	Parallel Bio 2020, Cambridge (United States), Series A	Limited information available	$25.4M	Refactor Capital, AIX Ventures & 8 others	58/100
10th	Clock.bio 2020, Cambridge (United Kingdom), Seed	Developer of treatments for age-related diseases using human pluripotent stem cells	$9.93M	LocalGlobe, Skyworthdigital & 6 others	55/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Pandorum's competitors? Click here to see the top ones

Founders own 23.96%, Funds own 18.80%, Enterprises own 21.21% and Angels (largest shareholder) own 25.08%. The net worth of Pandorum's founders is INR 192Cr as of Jan 21, 2026.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	23.96%	192Cr	8889027	8622729	6281559	7127713
Arun Chandru	3791773	3225780	1960447	4622774	4519484	5385052
Tuhin Bhowmick	3282489	2144032	8031020	7187917	5446554	7100192
Fund	18.80%	151Cr	9930989	8932834	2697636	6811269
Enterprise	21.21%	170Cr	9498871	1540531	6458305	5780065
Angel	25.08%	201Cr	5148879	8161603	9231784	9290545
Other People	4.77%	38.3Cr	7621	5899	9299	4538
ESOP Pool	6.19%	49.6Cr	876697	378839	502568	864854
Total	100.00%	802Cr	3415944	3105564	4828814	9899457